BioNexus Gene Lab
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BGLC and other ETFs, options, and stocks.About BGLC
BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases.
CEOSu Leng Tan Lee
CEOSu Leng Tan Lee
Employees30
Employees30
HeadquartersKuala Lumpur, Wilayah Perseketuan (Federal Territory)
HeadquartersKuala Lumpur, Wilayah Perseketuan (Federal Territory)
Founded2017
Founded2017
Employees30
Employees30
BGLC Key Statistics
Market cap6.84M
Market cap6.84M
Price-Earnings ratio-2.94
Price-Earnings ratio-2.94
Dividend yield—
Dividend yield—
Average volume6.84K
Average volume6.84K
High today$3.89
High today$3.89
Low today$3.76
Low today$3.76
Open price$3.76
Open price$3.76
Volume4.35K
Volume4.35K
52 Week high$15.60
52 Week high$15.60
52 Week low$2.01
52 Week low$2.01
Stock Snapshot
The current BioNexus Gene Lab(BGLC) stock price is $3.79, with a market capitalization of 6.84M. The stock trades at a price-to-earnings (P/E) ratio of -2.94.
During the trading session on 2026-01-15, BioNexus Gene Lab(BGLC) shares reached a daily high of $3.89 and a low of $3.76. At a current price of $3.79, the stock is +0.8% higher than the low and still -2.6% under the high.
Trading activity shows a volume of 4.35K, compared to an average daily volume of 6.84K.
The stock's 52-week range extends from a low of $2.01 to a high of $15.60.
The stock's 52-week range extends from a low of $2.01 to a high of $15.60.
People also own
Based on the portfolios of people who own BGLC. This list is generated using Robinhood data, and it’s not a recommendation.